Bepantol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bepantol

Property Description
Active Ingredient Dexpanthenol (D-Panthenol)
Pharmacological Class Provitamin (of Pantothenic Acid/Vitamin B5)
Common Use Support of skin repair and regeneration
Origin Synthetic derivative
Key Forms Cream, Ointment, Lotion, Sterile Injection

Bepantol is the trade name for pharmaceutical and dermatological preparations whose principal component is the medicinal substance Dexpanthenol. This compound is classified as a Provitamin and functions as a stable precursor to the essential B-group vitamin, Pantothenic Acid (Vitamin B5), necessary for numerous cellular metabolic functions. The medicinal entity is specifically the biologically active D-isomer, which ensures its metabolic utility and differentiates it from the less effective racemic forms of Panthenol.


What is Dexpanthenol and How is it Classified?

Dexpanthenol is a synthetic derivative and an alcoholic analogue of Pantothenic Acid that must undergo conversion within the cell to become functionally integrated into Coenzyme A (CoA). This classification establishes its role as a fundamental support molecule for metabolic processes. It is clinically recognized for its high penetrative ability, allowing for effective delivery of the Provitamin to the epidermis and underlying tissues. The substance possesses inherently low toxicity.


Composition, Forms, and General Therapeutic Purpose

The active core of Bepantol products is the single ingredient, Dexpanthenol, combined with various specialized vehicles. The medicine is supplied in several dosage forms, encompassing topical preparations such as cream, ointment, lotion, and spray, as well as a sterile aqueous solution for injection. The general therapeutic purpose is rooted in Dexpanthenol's ability to support the body’s innate processes of tissue regeneration. Topically, its primary function is to promote epithelial repair and act as a humectant; systemically, via the parenteral route, its function is related to specific needs like stimulating normal gastrointestinal motility.

What side effects are possible with Bepantol?

Possible Side Effects and Safety Information

The official regulatory safety documentation for Dexpanthenol (the active ingredient in Bepantol) generally describes a high safety profile with low incidence of adverse reactions. Side effects are primarily confined to the skin and immune system, reflecting the compound's low systemic absorption, particularly with topical formulations.


Official Classification of Adverse Reactions

Adverse reactions are mostly classified in official regulatory documents as Rare or Very rare. Severe systemic effects are sometimes classified as Not known due to the inability to accurately estimate their rate from available spontaneous reporting data.

System-Organ Class Officially Documented Reactions
Skin and subcutaneous tissue disorders Allergic skin reactions, contact dermatitis, pruritus (itching), erythema (redness), urticaria (hives/rash).
Immune system disorders Hypersensitivity reactions (including rare, severe systemic manifestations).

Administration-Agnostic Safety Considerations

The principal safety restriction documented in regulatory labeling is a contraindication for individuals with a known hypersensitivity to the active substance, Dexpanthenol, or any of the product’s excipients.

For topical use, regulatory documents note that prolonged use may increase the potential for localized skin reactions. Population-specific safety warnings for groups such as older adults or those with renal impairment are not typically listed, reinforcing the medicine’s generally high margin of safety across populations, especially in its topical form.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Bepantol

Feature Official Regulatory Statement
Documented overdose presentations: The official toxicological profile establishes a very low toxicity, leading to the regulatory conclusion that overdose, particularly from topical forms, is unlikely to result in serious adverse effects. Mild gastrointestinal distress is noted as a possible manifestation following accidental ingestion.
Physiological systems affected (as stated in label): No specific severe or life-threatening systemic effects are documented in official labeling. The mildest potential manifestation affects the gastrointestinal system.
Dose-related or exposure-related factors (if applicable): Overdose following topical application is unlikely. Accidental poisoning or over-dosage of certain topical formulations has not been reported in regulatory experience.
Population-specific overdose notes (if applicable): Accidental swallowing, particularly by a child, requires immediate referral to a doctor or hospital emergency room as a mandated emergency action.
Emergency-response statements (as written in official documents): Seek medical help or contact Poison Control following accidental ingestion. In the event of serious symptoms such as passing out or trouble breathing, call 911 (or local emergency services).
When immediate medical help is required (label-derived phrasing only): Immediate medical help is required in the event of accidental ingestion and for the occurrence of any serious symptoms.

Overdose classifications (high-level)

Feature Official Regulatory Statement
Severity classification (as defined in official documents): Classified as having very low toxicity; no measures are required in cases of overdose, reflecting a negligible level of concern for severe toxicity.
Regulatory basis (EMA / FDA / etc.): Information is based on SmPC/EMA-aligned and FDA-aligned prescribing information, as well as national health authority guidance.
Overdose-context constraints (as defined in official documents): No specific antidote is known. Management, if needed, is confined to standard symptomatic and supportive treatment.

Resulting overdose structure

Official overdose statements:

  • Very low toxicity is the established toxicological profile, making overdose from the active ingredient unlikely to cause serious adverse effects.
  • No specific antidote is known, and regulatory documentation states that no specific measures are required in cases of overdose due to the compound's safety profile.
  • Immediate referral to a doctor or hospital emergency room is mandated for cases of accidental swallowing, particularly in children.

Connection to the overall overdose profile: The official overdose profile is defined by the Dexpanthenol's documented status of very low toxicity, which determines the minimal risk of severe consequences. Consequently, regulatory documents mandate procedural help-seeking actions (contacting emergency services or Poison Control) primarily following accidental ingestion, particularly in the pediatric population, while simultaneously stating that no specific treatment or measures are required for the overdose itself.

Therapeutic Uses of Bepantol

Symptomatic Support and Therapeutic Relief

The product is applied across domains where additional symptomatic support is needed, addressing symptoms related to inflammatory or irritative states. It is used in situations involving certain distressing symptoms. This is commonly used across conditions presenting with acute episodes. This therapeutic domain is relevant in contexts marked by increased discomfort or tension, specifically for managing symptom clusters that may become intense or disruptive.

It helps ease the overall symptom load related to physical discomfort. The product is relevant for easing distress in conditions associated with heightened physiological stress, conditions where symptoms may intensify temporarily, and conditions presenting with systemic or localized discomfort. The product is used to assist patients: “It contributes to improved comfort during periods of heightened symptoms.”


QuickFact

Quick Fact: Relief for Physical Discomfort

The product is applied in clinical settings where short-term symptomatic assistance is needed, relevant in conditions characterized by periods of heightened symptoms. It offers symptomatic relief that helps patients cope more steadily with symptom fluctuations, and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

The eligibility profile for Dexpanthenol (the active core of Bepantol) is strictly defined by official regulatory documentation concerning specific population groups and pre-existing conditions.

Contraindicated Populations: The medicine is contraindicated in patients with a known hypersensitivity to Dexpanthenol or any component of the specific formulation. For systemic forms, patients with existing hypervitaminosis are also excluded from use as defined in the multivitamin prescribing information.

Age-Group Restrictions: While use is established for the general adult population, the safety and effectiveness of systemic Dexpanthenol have not been established in pediatric patients below 11 years of age. Use is therefore restricted to adults and children aged 11 years and above based on official labeling.

Conditional and Restricted Use: Use in pregnancy is classified as Category C, meaning it is allowed only if the clinical benefit clearly outweighs the potential risk. Caution should be exercised in nursing mothers, as its excretion into human milk is not confirmed. Systemic administration is also restricted from occurring within one hour of succinylcholine administration. Conditional use is required for patients with hepatic or renal impairment when the drug is used as a multivitamin component.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation for the active ingredient, Dexpanthenol, primarily addresses interactions involving its systemic, sterile injection form, as topical preparations typically lack systemic exposure sufficient for drug-drug interactions.

Documented Drug-Drug Interaction Structure

The most significant interaction involves a pharmacodynamic potentiation with the neuromuscular blocking agent succinylcholine. Official labeling states that Dexpanthenol co-administration prolongs the effects of succinylcholine. Consequently, a mandatory timing restriction requires that Dexpanthenol Injection must not be administered within one hour of succinylcholine.

Additional regulatory warnings address potential adverse event risks during co-administration with other agents. Rare instances of allergic reactions of unknown cause have been reported during concomitant use with certain antibiotics, narcotics, and barbiturates.

Procedural Interaction Constraints

For the injection form, specific procedural constraints are necessary: Dexpanthenol is physically incompatible with moderately alkaline solutions, such as sodium bicarbonate or aminophylline, and must not be mixed with these solutions in an intravenous infusion. Regulatory documents do not explicitly state clinically significant interactions with food, alcohol, or herbal products.

Mechanism of Action

Dexpanthenol is a provitamin metabolized into pantothenic acid (vitamin B5) within epidermal cells, primarily keratinocytes and fibroblasts. This conversion positions pantothenic acid as a necessary precursor for the biosynthesis of Coenzyme A (CoA).

The subsequent increase in intracellular CoA levels facilitates the synthesis of essential epidermal lipids, including ceramides and cholesterol. This molecular cascade contributes to the structural stabilization and maintenance of the stratum corneum and its barrier function.

Additionally, dexpanthenol activity supports fibroblast proliferation and enhances the synthesis of extracellular matrix proteins, such as collagen. This downstream effect is linked to the cellular regulation of the skin's biological processes and tissue structural integrity.

Dosage and Administration Information

The administration of Dexpanthenol (Bepantol) is defined by two distinct use protocols: topical and parenteral.

Administration Scope

Administration routes include topical/cutaneous application for creams and ointments, as well as parenteral administration via the intramuscular (IM) route. Intravenous (IV) use is restricted to slow infusion following strict dilution protocols. For parenteral use, the standard dose for adynamic ileus treatment is typically 500 mg, administered on a fixed, repeating schedule.

Dosing and Frequency Schedule

For the injection, the dose is repeated every six hours following the initial administration, continuing until the acute clinical status resolves. Topical preparations are applied to the affected area, with dosing frequency commonly defined as once daily or every 12 hours, or as often as necessary for specific needs such as infant diaper care. While topical forms are used for infants, specific pediatric dosing for the parenteral injection is not established.

Preparation and Special Conditions

Parenteral administration requires the solution to be diluted in a bulk IV solution before slow infusion; direct IV injection is not advised. A special constraint dictates that the injection must not be administered within one hour of succinylcholine.

Connection to the Overall Use Protocol

This framework dictates that the medicine’s use is governed by a clear distinction between the external application protocol and the conditional, time-bound regimen required for its internal administration. These instructions define the precise numerical dosage, the conditional frequency, and the mandatory preparation steps to ensure the medicine is administered in accordance with established standards.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bepantol


Evidence for Topical Skin Conditions: Epithelial Repair & Symptom Relief

Research exploring topical Dexpanthenol has been conducted using Randomized Controlled Trials (RCTs) and controlled models that involved experimental skin irritation. These studies were studied for conditions involving minor wounds, burns, diaper rash models, and recovery after dermatological procedures.

Research examined objective skin barrier function metrics, including Transepidermal Water Loss (TEWL) and hydration. Studies also monitored the speed of re-epithelialization and assessed subjective outcomes like redness (erythema) and discomfort. Findings describe patterns observed in these short-term studies, and research highlights changes measured during the study period concerning skin barrier properties. What remains uncertain is the limited information for long-term outcomes, and the difficulty in distinguishing the compound's effects from patterns observed with the product's vehicle.


Evidence for Specialized Ophthalmic Use

Dexpanthenol was studied for use in specialized sterile eye preparations, with research including Randomized Controlled Trials and non-inferiority trials. These studies were evaluated in populations recovering from corneal surgery and those dealing with dry eye syndrome. Trials examined outcomes related to physical discomfort and monitored re-epithelialization time. Reported outcomes reflect the specific conditions under which they were conducted. The volume of published trials for this specific specialized use is sometimes described as small, and the certainty remains low in these areas.


Research in Specific Patient Groups and Scientific Gaps

Research was observed in healthy adult volunteers and specific populations such as patients with Atopic Dermatitis. Studies explored responses in infants using specialized models. Overall, the results apply only to the populations studied. A primary limitation is that a significant number of studies utilized modest sample sizes. Findings describe group patterns, not personal outcomes. Research provides context but not individual predictions. Follow-up durations were limited in many key trials, and the long-term effects are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Bepantol (FAQ)

Q: What is the key difference between Bepantol Cream and Bepantol Ointment formulations?

The main difference between the Cream and Ointment formulations is the oil-to-water ratio. Ointments typically contain a higher proportion of oil, which helps create a protective seal on the skin. Creams have a more balanced composition, making them lighter and easier to spread.

Q: Is Bepantol a steroid-based product or is it steroid-free?

Official information confirms that Dexpanthenol, the active ingredient, is classified as a provitamin, which is a precursor to Vitamin B5. It is not classified as a corticosteroid. Therefore, the product is free from steroid-based medicinal ingredients.

Q: Can Bepantol be purchased over-the-counter without a prescription?

According to regulatory status in many major regions, the topical form of Dexpanthenol is available for purchase without a prescription. It is widely classified as an over-the-counter (OTC) product for external use.

Q: Can Bepantol be used on skin that is intact and not broken or wounded?

Official documents indicate the product's intended purpose includes acting as a humectant and emollient, which means it helps the skin retain moisture. This function is beneficial for general skin health and repair on a variety of skin surfaces, including those that are intact.

Q: Is Bepantol intended strictly for skin application, or can it be used on hair and nails?

The medicine is primarily approved for topical application to the skin and for specific systemic uses. Applications for non-medical purposes, such as cosmetic use on hair or nails, are not included in the official drug indications.

Q: Can Bepantol be applied to skin that has been irritated by sun exposure?

The regulatory indications for the product include relief for general skin irritation and minor burns. The specific product label should be reviewed for use instructions related to sun exposure.

Q: Is Bepantol suitable for daily use on the face?

Official product warnings generally advise that topical products are for external use only and that contact with the eyes should be avoided. Regulatory documents do not specifically place restrictions against application on the face, but it is generally applied to the affected area.

Q: Why do many people use Bepantol products as part of a routine for dry lips?

The general indications for the topical preparation include relief from dryness, chafing, and irritation. Since dry lips are a form of localized skin dryness, the product's use falls within the scope of its general indications.

Q: Is it normal for the ointment formulation of Bepantol to feel sticky or greasy when first applied?

Ointments, by definition, have a higher oil content than creams, which is intended to provide a protective, occlusive layer. This high oil content means the ointment may feel thicker or greasier when first applied, which is consistent with its intended formulation.

Q: Does Bepantol work by creating a barrier, or does it help the skin retain its own moisture?

Official information describes the product's action in two ways. It is classified as a humectant, meaning it attracts and helps the skin retain moisture. Additionally, its metabolic action helps stabilize and maintain the skin’s natural barrier function.

Q: In which specific circumstances is Bepantol recommended for use only under the guidance of a healthcare professional?

The medicine is subject to constraints requiring careful review of conditions for specific populations and uses. These include use in pregnancy, for nursing mothers, in cases of hepatic or renal impairment (when used as a multivitamin component), and when the sterile injection form is used near succinylcholine.

Q: What distinguishes Bepantol from a standard, non-medicated moisturizing lotion?

Bepantol is classified as a medicinal substance because its active ingredient, Dexpanthenol, is a provitamin. This provitamin converts into Vitamin B5 within the cells to help support Coenzyme A synthesis and tissue repair. Standard, non-medicated moisturizers do not have this active metabolic function.

Q: Is the use of Bepantol products suitable for both children and infants?

The suitability depends on the product form. Topical preparations are widely used for infants, such as for diaper care. However, the sterile injection form used for systemic administration has age restrictions and is generally established only for adults and children aged 11 years and above.

Q: Does Bepantol contain any inactive ingredients that are common skin irritants or allergens?

Official safety information advises a contraindication for individuals with a known hypersensitivity to Dexpanthenol or any of the product’s excipients (inactive ingredients). This constraint is based on the risk of hypersensitivity to any component.

Q: Is it safe to use Bepantol if I am already taking a vitamin B complex or oral B5 supplement?

The systemic (injection) form is contraindicated in cases of hypervitaminosis, which is an excessive accumulation of vitamins. While the topical form has low absorption into the bloodstream, individuals taking oral B vitamin supplements may want to discuss co-administration with a healthcare professional.

Q: How does the safety information for Bepantol vary for different age demographics?

The safety profile is generally described as high, particularly for the topical form. Systemic use has age restrictions and is limited to children 11 years and older. Official documents typically do not list specific safety warnings for older adults or those with renal impairment, which reinforces its generally high safety margin for topical use.

Q: Are there any specific skin conditions mentioned in regulatory warnings against using Bepantol?

The primary restriction for topical use is a known hypersensitivity to any of the product’s components. For the systemic (injection) form, there is a specific contraindication regarding its use in patients with hemophilia (a bleeding disorder) due to regulatory warnings about bleeding risk on wounds.

Q: What should be done if Bepantol is accidentally ingested?

Accidental ingestion of the topical form is considered unlikely to result in serious adverse effects, though it may cause temporary gastrointestinal distress. In cases of ingestion, medical assistance or contacting Poison Control may be necessary.

Q: Does the product formula for Bepantol change between different countries or regions?

Official regulatory requirements regarding the formulation of topical drug products, especially for inactive ingredients (excipients), can differ across global markets. This means that minor variations in the product's final composition may exist between different countries or regions.

Q: Is Bepantol described as having a notable anti-inflammatory property in scientific literature?

Scientific literature describes that Dexpanthenol is observed to possess anti-inflammatory properties in certain studies. This potential mechanism may be one component of the substance's overall tissue-protective and regenerative effects.

Q: What is the general regulatory status of Bepantol-containing products in major global markets?

The topical preparation containing Dexpanthenol is generally regulated as an over-the-counter (OTC) medicine in the world's major markets. This status is based on its intended use for external application for skin support.

How should Bepantol be stored and disposed of?

The official storage and disposal instructions for Bepantol (Dexpanthenol) are defined by regulatory authorities to ensure product stability and patient safety.

Storage Requirements

Storage Component Official Labeled Requirement
Temperature Range Store below 25 C or 30 C (check specific label); Do not freeze.
Protection Protect from light and protect from moisture.
Container Rule Keep in the original container and keep the container tightly closed.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Disposal must be conducted in accordance with local requirements for unused medicinal products. The labeling instructs that the medicine must not be thrown away via wastewater or household waste (unless explicitly approved by regulators). Use an established medicine take-back program or follow local guidelines for proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bepantol found in:

A-Z Index: